Details of the Drug

General Information of Drug (ID: DM5Q9BU)

Drug Name
Pleo zinc
Synonyms Zinkgluconaat; Zinc gluconate [USP]; U6WSN5SQ1Z; Rubozine; BioZn-AAS; gluconate zinc
Indication
Disease Entry ICD 11 Status REF
Coronavirus Disease 2019 (COVID-19) 1D6Y Investigative [1]
Affected Organisms
Humans and other mammals
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C12H24O14Zn
Canonical SMILES
C(C(C(C(C(C(=O)O)O)O)O)O)O.C(C(C(C(C(C(=O)O)O)O)O)O)O.[Zn]
InChI
1S/2C6H12O7.Zn/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/t2*2-,3-,4+,5-;/m11./s1
InChIKey
ZSKINHGFQOKUDM-IYEMJOQQSA-N
Cross-matching ID
PubChem CID
20543
CAS Number
4468-02-4
UNII
U6WSN5SQ1Z
DrugBank ID
DB11248
TTD ID
D0GH8X

References

1 Potential role of zinc supplementation in prophylaxis and treatment of COVID-19. Med Hypotheses. 2020 May 25;144:109848.